Last Updated: September 28, 2026

Alvogen Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ALVOGEN

ALVOGEN has fifty-three approved drugs.

There are two tentative approvals on ALVOGEN drugs.

Drugs and US Patents for Alvogen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 206840-003 Sep 15, 2016 DISCN No No ⤷  Start Trial ⤷  Start Trial
Alvogen CICLOPIROX ciclopirox GEL;TOPICAL 020519-001 Jul 21, 1997 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Alvogen ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 204674-001 Feb 11, 2014 AN RX No No ⤷  Start Trial ⤷  Start Trial
Alvogen DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 207388-004 Jul 28, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial
Alvogen METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET, EXTENDED RELEASE;ORAL 210818-004 Nov 30, 2018 DISCN No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alvogen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 4,005,209 ⤷  Start Trial
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 4,012,444 ⤷  Start Trial
Alvogen CICLOPIROX ciclopirox GEL;TOPICAL 020519-001 Jul 21, 1997 7,018,656 ⤷  Start Trial
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 4,012,444 ⤷  Start Trial
Alvogen LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 3,592,930 ⤷  Start Trial
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 4,642,384 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.